2.1 Key figures
6 months (unaudited) ended at 30 June, in CHF millions
2023 |
2022 |
Change |
|
---|---|---|---|
Net revenue |
602.7 |
541.6 |
+11.3 % |
EBITDA1 |
100.4 |
109.9 |
–8.6 % |
as % of net revenue |
16.7 % |
20.3 % |
n/a |
Operating result (EBIT) |
60.5 |
72.5 |
–16.6 % |
as % of net revenue (EBIT margin) |
10.0 % |
13.4 % |
n/a |
Net result |
32.1 |
57.4 |
–44.1 % |
as % of net revenue |
5.3 % |
10.6 % |
n/a |
ROCE (LTM)1,3 |
15.0 % |
18.6 %2 |
n/a |
Average capital employed1 |
915.8 |
804.9 |
+13.8 % |
Net cash from operating activities |
95.9 |
36.0 |
+166.4 % |
Net cash used in investing activities |
–34.7 |
–649.1 |
–94.7 % |
Free cash flow1 |
61.2 |
–613.1 |
n/a |
Net cash used in financing activities |
–70.5 |
485.9 |
n/a |
Net change in cash and cash equivalents1 |
–9.3 |
–127.2 |
–92.7 % |
Cash and cash equivalents |
90.2 |
93.0 |
–3.0 % |
Capital expenditures1 |
29.2 |
47.9 |
–39.0 % |
Total assets |
1'251.8 |
1'309.6 |
–4.4 % |
Equity |
370.3 |
369.8 |
+0.1 % |
as % of total assets |
29.6 % |
28.2 % |
n/a |
Number of employees at 30 June |
8'384 |
8'802 |
–4.7 % |
Full-time equivalents at 30 June |
8'234 |
8'679 |
–5.1 % |
The definition of alternative performance measures and adjustments, not defined by Swiss GAAP, are provided in the Half-Year Financial Report 2023 under Alternative Performance Measures.
Adjusted
ROCE is calculated by dividing the operating result (EBIT) of the last twelve months (= LTM) by the average capital employed of the same period.
Key figures Healthcare Solutions
2023 |
2022 |
Change |
|
---|---|---|---|
Net revenue |
253.8 |
265.7 |
–4.5 % |
Operating result (EBIT) |
39.8 |
58.0 |
–31.4 % |
as % of net revenue (EBIT margin) |
15.7 % |
21.8 % |
n/a |
Key figures Industrial Solutions
2023 |
2022 |
Change |
|
---|---|---|---|
Net revenue1 |
351.8 |
279.5 |
25.9 % |
Operating result (EBIT) |
20.7 |
14.5 |
42.8 % |
as % of net revenue (EBIT margin) |
5.9 % |
5.2 % |
n/a |
Including intercompany revenue of CHF 2.9 million in 2023 and CHF 3.6 million in 2022.
2.3 Consolidated
Financial Statements
Consolidated Income Statement
Consolidated Balance Sheet
Condensed Consolidated Cash Flow Statement
Consolidated Statement of Changes in Equity
Notes to the Consolidated Financial Statements
Alternative Performance Measures (APM)